PKU EASY Microtabs Plus - Acceptability and Tolerance
NCT06694662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2025-11-26
Summary
PEMP-AT is a prospective, single-arm, open-label, 1-week acceptability study to evaluate PKU EASY Microtabs Plus for the dietary management of participants with phenylketonuria (PKU). Up to 10 participants aged 3 years and above will be recruited in a single-centre in the UK.
Conditions
- Phenylketonuria (PKU)
Interventions
- DIETARY_SUPPLEMENT
-
PKU EASY Microtabs Plus
PKU EASY Microtabs Plus is a food for special medical purposes (FSMP). This product is for use in the dietary management of Phenylketonuria (PKU) in patients from 3 years of age upwards. PKU EASY Microtabs Plus is a microtablet form, slow-release, phenylalanine-free protein substitute containing a blend of essential and non-essential amino acids, vitamins, minerals and trace elements.
Sponsors & Collaborators
-
Birmingham Women's and Children's NHS Foundation Trust
collaborator OTHER -
Galen Limited
lead INDUSTRY
Principal Investigators
-
Anita MacDonald, Ph.D. · Birmingham Women's and Children's NHS Foundation Trust
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-15
- Primary Completion
- 2025-08-13
- Completion
- 2025-08-13
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluation of the Express Plus Range
NCT05051657 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Cereals for Atopic Children
NCT01029184 ·Status: TERMINATED ·Phase: NA
-
A Study to Assess the Safety of TPM502 in Adults With Celiac Disease
NCT05660109 ·Status: COMPLETED ·Phase: PHASE2
-
Food Oral Immunotherapy for Peanut Allergy
NCT04222491 ·Status: ACTIVE_NOT_RECRUITING
-
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
NCT04530123 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
NCT05353985 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerance Following Peanut Oral Immunotherapy
NCT01750879 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Endophenotyping for Plant-based Food Allergy Diagnosis, Tolerance Biomarkers, and Mechanisms in Microneedle Immunotherapy
NCT06997432 ·Status: NOT_YET_RECRUITING
-
"Gluten Friendly" Treatment in Celiac Disease
NCT03137862 ·Status: COMPLETED ·Phase: NA
-
Non Celiac Gluten Sensitivity, DBPCFC in Adolescents
NCT04639921 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.
NCT03680066 ·Status: TERMINATED ·Phase: NA
-
Study of Tolerance to Oral Peanut
NCT01259804 ·Status: COMPLETED ·Phase: PHASE1
-
Gastric Gluten-Degradation Activity of PvP001
NCT03594331 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
NCT03738475 ·Status: COMPLETED ·Phase: PHASE2
-
Persistence of Oral Tolerance to Peanut
NCT01366846 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients
NCT02960074 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease
NCT03857360 ·Status: COMPLETED ·Phase: NA
-
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
NCT04243551 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
NCT06982963 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac Disease
NCT03701555 ·Status: COMPLETED ·Phase: PHASE1
-
Mixed Tree Nut Food Challenges
NCT02070263 ·Status: UNKNOWN
-
Carbohydrate Counting and DASH Intervention Among Children With Diabetes and Celiac Disease.
NCT05132725 ·Status: UNKNOWN ·Phase: NA
-
ARTEMIS Peanut Allergy In Children
NCT03201003 ·Status: COMPLETED ·Phase: PHASE3
-
Food Challenge With Barley Starch as Active Comparator
NCT03352856 ·Status: SUSPENDED ·Phase: NA
-
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)
NCT05574010 ·Status: TERMINATED ·Phase: PHASE1/PHASE2